320 related articles for article (PubMed ID: 31746410)
1. Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next‑generation sequencing.
Wu H; Wang Q; Zhong H; Li L; Zhang Q; Huang Q; Yu Z
Oncol Rep; 2020 Jan; 43(1):240-250. PubMed ID: 31746410
[TBL] [Abstract][Full Text] [Related]
2. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
3. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.
Stevic I; Müller V; Weber K; Fasching PA; Karn T; Marmé F; Schem C; Stickeler E; Denkert C; van Mackelenbergh M; Salat C; Schneeweiss A; Pantel K; Loibl S; Untch M; Schwarzenbach H
BMC Med; 2018 Oct; 16(1):179. PubMed ID: 30301470
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
[TBL] [Abstract][Full Text] [Related]
6. Circulating exosomal microRNAs as biomarkers of colon cancer.
Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
[TBL] [Abstract][Full Text] [Related]
8. Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer.
Feng W; Li Y; Chu J; Li J; Zhang Y; Ding X; Fu Z; Li W; Huang X; Yin Y
Cancer Med; 2018 Oct; 7(10):5130-5144. PubMed ID: 30239174
[TBL] [Abstract][Full Text] [Related]
9. Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome.
Jiang X; Li J; Zhang B; Hu J; Ma J; Cui L; Chen ZJ
Fertil Steril; 2021 Mar; 115(3):782-792. PubMed ID: 33041053
[TBL] [Abstract][Full Text] [Related]
10. Exosome-Derived MiRNAs as Biomarkers of the Development and Progression of Intracranial Aneurysms.
Liao B; Zhou MX; Zhou FK; Luo XM; Zhong SX; Zhou YF; Qin YS; Li PP; Qin C
J Atheroscler Thromb; 2020 Jun; 27(6):545-610. PubMed ID: 31597886
[TBL] [Abstract][Full Text] [Related]
11. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
12. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
13. A panel of eight microRNAs is a good predictive parameter for triple-negative breast cancer relapse.
Hong HC; Chuang CH; Huang WC; Weng SL; Chen CH; Chang KH; Liao KW; Huang HD
Theranostics; 2020; 10(19):8771-8789. PubMed ID: 32754277
[No Abstract] [Full Text] [Related]
14. Identification of dysregulated microRNAs associated with diagnosis and prognosis in triple‑negative breast cancer: An in silico study.
Fan C; Liu N
Oncol Rep; 2019 Jun; 41(6):3313-3324. PubMed ID: 30942465
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
[TBL] [Abstract][Full Text] [Related]
16. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of serum-related exosomal miRNAs from parathyroid tumor.
Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B
Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496
[TBL] [Abstract][Full Text] [Related]
19. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
Schwarzenbach H
Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441
[TBL] [Abstract][Full Text] [Related]
20. Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset.
Zhong D; Wu C; Xu D; Bai J; Wang Q; Zeng X
Biomed Res Int; 2021; 2021():6676107. PubMed ID: 34368354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]